Clinical Trials Browser

Adenocarcinoma, Erectile Dysfunction, Prostatic Neoplasms

NCT07455422 2026-03-06

Endeavor-2

Phase NA Not yet recruiting

266 enrolled

Gastrointestinal

Adenocarcinoma, Barrett Esophagus

NCT07444983 2026-03-03

Rezvilutamide for High-Risk Prostate Cancer After Surgery

Phase NA Not yet recruiting

33 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06834204 2026-02-25

ACCESS-PC

Phase NA Not yet recruiting

266 enrolled

GenitourinaryGynecologic

Adenocarcinoma, Urinary Bladder Neoplasms, Diabetes Mellitus, Hypercholesterolemia, Hyperlipidemias, Hypertension, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Clinical Trials

PRIAPUS-PCa

Endeavor-2

Rezvilutamide for High-Risk Prostate Cancer After Surgery

ACCESS-PC

PRO-BOOST-LC

Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Lutécio

TA-P-OLIM

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

CONVERT-HB1

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

PROSTIA- BP

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

PCS-XII

URO-ROBOT-2023

Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer

TRACE

Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer